These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1927130

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The effect of physical training on the pharmacokinetics of steroidal contraceptives].
    Klinger G, Seidel E, Carol W, Boer J, Pocha C.
    Zentralbl Gynakol; 1991; 113(22):1240-5. PubMed ID: 1755260
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
    Carol W, Klinger G, Jäger R, Kasch R, Brandstädt A.
    Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of ethinyl estradiol following the administration of combination contraceptive preparations].
    Carol W, Klinger G, Jäger R, Kasch R.
    Zentralbl Gynakol; 1990; 112(3):135-41. PubMed ID: 2336888
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [Abstract] [Full Text] [Related]

  • 7. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP, Mathias A.
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
    Stanczyk FZ, Lobo RA, Chiang ST, Woutersz TB.
    Contraception; 1990 Jan; 41(1):39-53. PubMed ID: 2105872
    [Abstract] [Full Text] [Related]

  • 9. The effect of olestra on systemic levels of oral contraceptives.
    Miller KW, Williams DS, Carter SB, Jones MB, Mishell DR.
    Clin Pharmacol Ther; 1990 Jul; 48(1):34-40. PubMed ID: 2196143
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C.
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [Abstract] [Full Text] [Related]

  • 12. Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
    Joshi JV, Sankolli GM, Shah RS, Joshi UM.
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):192-5. PubMed ID: 3086241
    [Abstract] [Full Text] [Related]

  • 13. Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women.
    Ragueneau-Majlessi I, Levy RH, Janik F.
    Epilepsia; 2002 Jul; 43(7):697-702. PubMed ID: 12102671
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
    Trapnell CB, Donahue SR, Collins JM, Flockhart DA, Thacker D, Abernethy DR.
    Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR, Colburn W, Kook KA, Thomas SD.
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [Abstract] [Full Text] [Related]

  • 18. Influence of avosentan (SPP3OI) on the pharmacokinetics of a second generation oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
    Dieterle W, Mann J.
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):668-74. PubMed ID: 17190377
    [Abstract] [Full Text] [Related]

  • 19. [Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
    Albus C, Männchen E.
    Zentralbl Gynakol; 1987 Dec; 109(8):521-6. PubMed ID: 3111130
    [Abstract] [Full Text] [Related]

  • 20. [Dermatologic complications of oral hormonal contraception (Gravistat)].
    Mikrut W.
    Wiad Lek; 1986 Nov 01; 39(21):1462-5. PubMed ID: 3577158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.